Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • In Brief
  • Published:

Tumour suppression

PTEN gains new powers

Nature Reviews Cancer volume 15, page 575 (2015)Cite this article

Subjects

Access through your institution
Buy or subscribe

Caserta et al. investigated the effects of a cancer-associated mutation in PTEN (PTENFV). They generated PtenFV knock-in mice: the homozygous mice had intact AKT signalling and developed normally; the heterozyogus mice developed several types of carcinoma, none of which was usually associated with Pten deficiency. This mutation therefore exposes a new role for PTEN in tumour suppression that requires further investigation.

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Caserta, E. et al. Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo. Genes Dev. 29, 1707–1720 (2015)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Authors
  1. Gemma K. Alderton
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alderton, G. PTEN gains new powers. Nat Rev Cancer 15, 575 (2015). https://doi.org/10.1038/nrc4026

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nrc4026

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer